ARS-1620
ARS-1620 is a selective, covalent small molecule inhibitor that targets the oncogenic K-RASG12C mutant protein. It is widely used in cancer research, demonstrating potent anti-tumor activity in both in vitro cellular assays and in vivo xenograft models.
Product Specifications
CAS Number
1698055-85-4
Product Name Alternative
Inhibit, KRAS G12C, Inhibitor, ARS 1620, ARS1620, ARS-1620, Ras
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.64 mM) ; DMSO:53 mg/mL (123.02 mM)
Smiles
Oc1cccc (F) c1-c1c (Cl) cc2c (ncnc2c1F) N1CCN (CC1) C (=O) C=C
Molecular Formula
C21H17ClF2N4O2
Molecular Weight
430.84
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2169367-01 0.1 mL
FITC-Linked Polyclonal Antibody to Vesicle Docking Protein (VDP)
Sign In for Pricing
View Details MBS2169367-02 0.2 mL
FITC-Linked Polyclonal Antibody to Vesicle Docking Protein (VDP)
Sign In for Pricing
View Details MBS2169367-03 0.5 mL
FITC-Linked Polyclonal Antibody to Vesicle Docking Protein (VDP)
Sign In for Pricing
View Details MBS2169367-04 1 mL
FITC-Linked Polyclonal Antibody to Vesicle Docking Protein (VDP)
Sign In for Pricing
View Details MBS2169367-05 5 mL
FITC-Linked Polyclonal Antibody to Vesicle Docking Protein (VDP)
Sign In for Pricing
View Details MBS2169367-06 5x 5 mL
FITC-Linked Polyclonal Antibody to Vesicle Docking Protein (VDP)
Sign In for Pricing
View Details